Potentiation of the algogenic action of bradykinin by an inhibitor of angiotensin I converting enzyme, captopril (SQ 14,225).
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001920:Bradykinin / Q000008:administration & dosage / Q000494:pharmacology*; D002216:Captopril / Q000494:pharmacology*; D004285:Dogs; D004357:Drug Synergism; D005260:Female; D005263:Femoral Artery; D007269:Injections, Intra-Arterial; D008297:Male; D008638:Mesenteric Arteries; D010146:Pain / Q000139:chemically induced*; D007703:Peptidyl-Dipeptidase A / Q000494:pharmacology*; D011392:Proline / Q000031:analogs & derivatives*; D014828:Vocalization, Animal
D011392:Proline; D002216:Captopril; D007703:Peptidyl-Dipeptidase A; D000109:Acetylcholine; D001920:Bradykinin